Zonisamide in refractory essential tremor;Zonisamida en el temblor esencial refractario

Revista de Neurologia

Volumn 46, Issue 3, 2008, Pages 139-142

  Bermejo, Pedro Emilio ^a,b   Ruiz Huete, C ^a   Dorado, R ^a   Anciones, B ^a  

^a Hospital de la Zarzuela   (Spain)

^b La Zarzuela University Hospital and La Moraleja University Hospital   (Spain)

Author keywords

Antiepileptic; Essential tremor; Treatment; Zonisamide

Indexed keywords

GABAPENTIN; PRIMIDONE; PROPRANOLOL; TOPIRAMATE; ZONISAMIDE;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DATA ANALYSIS; DISEASE DURATION; DRUG EFFICACY; DRUG TOLERABILITY; ESSENTIAL TREMOR; FEMALE; HUMAN; MALE; NEUROLOGIC EXAMINATION; SEX RATIO; TREATMENT OUTCOME;

EID: 40849088174     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.4603.2007523     Document Type: Article

References (38)

1. Lou JS, Jankovic J. Essential tremor: clinical correlates in 350 patients. Neurology 1991; 41: 234-8.
2. Louis ED, Ottman R, Hauser WA. How common is the most common adult movement disorder?: estimates of the prevalence of essential tremor throughout the world. Mov Disord 1998; 13: 5-10.
3. Dogu O, Sevim S, Camdeviren H, Sasmaz T, Bugdayci R, Aral M, et al. Prevalence of essential tremor: door-to-door neurological exams in Mersin province, Turkey. Neurology 2003; 61: 1804-7.
4. Koller WC, Vetere-Overfield B. Acute and chronic effects of propranolol and primidone in essential tremor. Neurology 1989; 39: 1587-8.
5. Bermejo PE. Tratamiento del temblor esencial. Med Clin (Barc) 2007; 129: 222-7.
6. Benito-León J, Louis ED. Clinical update: diagnosis and treatment of essential tremor. Lancet 2007; 369: 1152-4.
7. Baulac M, Leppik IE. Efficacy and safety of adjunctive zonisamide therapy for refractory partial seizures. Epilepsy Res 2007; 75: 75-83.
8. Frampton JE, Scott LJ. Zonisamide: a review of its use in the management of partial seizures in epilepsy. CNS Drugs 2005; 19: 347-67.
9. Morita S, Miwa H, Kondo T. Effect of zonisamide on essential tremor: a pilot crossover study in comparison with arotinolol. Parkinsonism Relat Disord 2005; 11: 101-3.
10. Zesiewicz TA, Ward CL, Hauser RA, Sánchez-Ramos J, Staffetti JF, Sullivan KL. A double-blind placebo-controlled trial of zonisamide (zonegran) in the treatment of essential tremor. Mov Disord 2007; 22: 279-82.
11. Bain P, Brin M, Deuschl G, Elble R, Jankovic J, Findley L, et al. Criteria for the diagnosis of essential tremor. Neurology 2000; 54: 7.
12. Mulleners WM, Whitmarsch TE, Steiner TJ. Noncompliance may render migraine prophylaxis useless, but once-daily regimens are better. Cephalalgia 1998; 18: 52-6.
13. Krusz JC. Zonisamide in the treatment of headache disorders [abstract]. Cephalalgia 2001; 21: 374-5.
14. Bernstein CD, Diaz JH, Gould HJ. A possible role for zonisamide in treating neuropathic pain: a case of idiopathic polyneuropathy. Pain Pract 2002; 2: 134-6.
15. Ghaemi SN, Zablotsky B, Filkowski MM, Dunn RT, Pardo TB, Isenstein E, et al. An open prospective study of zonisamide in acute bipolar depression. J Clin Psychopharmacol 2006; 26: 385-8.
16. Ashkenazi A, Benlifer A, Korenblit J, Silberstein SD. Zonisamide for migraine prophylaxis in refractory patients. Cephalalgia 2006; 26: 1199-202.
17. Pakalnis A, Kring D. Zonisamide prophylaxis in refractory pediatric headache. Headache 2006; 46: 804-7.
18. Morgan JC, Sethi KD. Zonisamide in Parkinson's disease. Curr Neurol Neurosci Rep 2007; 7: 275-7.
19. Wang PW, Yang YS, Chandler RA, Nowakowska C, Alarcon AM, Culver J, et al. Adjunctive zonisamide for weight loss in euthymic bipolar disorder patients: A pilot study. J Psychiatr Res 2007; Jul 10 [Epub ahead of print].
20. Kinrys G, Vasconcelos E, Sa D, Nery F. Adjunctive zonisamide for treatment refractory anxiety. Int J Clin Pract 2007; 61: 1050-3.
21. McElroy SL, Kotwal R, Guerdjikova AI, Welge JA, Nelson EB, Lake KA, et al. Zonisamide in the treatment of binge eating disorder with obesity: a randomized controlled trial. J Clin Psychiatry 2006; 67: 1897-906.
22. Bermejo PE. Zonisamide in patients with essential tremor and Parkinson's disease. Mov Disord 2007; 22: 2137-8.
23. Koller WC, Royse WL. Efficacy of primidone in essential tremor. Neurology 1986; 36: 121-4.
24. Bermejo PE, Dorado R. Topiramato en el temblor esencial refractario. Rev Neurol 2007; 45: 188-9.
25. López del Val JL, Santos S. Gabapentina en el tratamiento del temblor. Rev Neurol 2003; 36: 322-6.
26. Zesiewicz TA, Ward CL, Hauser RA, Salemi JL, Siraj S, Wilson MC, et al. A pilot, double-blind, placebo-controlled trial of pregabalin (Lyrica) in the treatment of essential tremor. Mov Disord 2007; 22: 1660-3.
27. Raj V, Landess JS, Martin PR. Oxcarbazepine use in essential tremor. Ann Pharmacother 2006; 40: 1876-9.
28. Sanz-Cartagena P, Fossas P, Floriach-Robert M, Serra-Prat M, Cano A, Palomeras E. Eficacia y tolerabilidad del levetiracetam en pacientes con temblor esencial: datos de un ensayo abierto de 11 semanas de seguimiento. Rev Neurol 2007; 45: 134-6.
29. Bermejo PE, Velasco R. Nuevos fármacos antiepilépticos en la profilaxis de la migraña. Med Clin (Barc) 2007; 128: 379-82.
30. Bermejo-Velasco PE, Velasco-Calvo R. Nuevos fármacos antiepilépticos y dolor neuropático. De la medicina molecular a la clínica. Med Clin (Barc) 2007; 129: 542-50.
31. Bazil CW. Anticonvulsant drug or neuromodulator? The growing case for anticonvulsant uses beyond epilepsy. Curr Neurol Neurosci Rep 2004; 4: 305-7.
32. Oommen KJ, Mathews S. Zonisamide: a new antiepileptic drug. Clin Neuropharmacol 1999; 22: 192-200.
33. Schauf CL. Zonisamide enhances slow sodium inactivation in Myxicola. Brain Res 1987; 413: 185-8.
34. Kito M, Maehara M, Watanabe K. Mechanisms of T-type calcium channel blockade by zonisamide. Seizure 1996; 5: 115-9.
35. Biton V. Clinical pharmacology and mechanism of action of zonisamide. Clin Neuropharmacol 2007; 30: 230-40.
36. Murata M. Novel therapeutic effects on the anti-convulsant, zonisamide on Parkinson's disease. Curr Pharm Des 2004; 10: 687-93.
37. Bermejo PE, Zabala JA, Sáez R. Restless legs syndrome induced by zonisamide. Mov Disord 2007; 22: 1517-8.
38. Mago R, Huege S, Ahuja N, Kunkel EJ. Zonisamide-induced suicidal ideation. Psychosomatics 2006; 47: 68-9.